139 related articles for article (PubMed ID: 12945527)
1. Antiretrovirals and cardiovascular disease: is HAART bad for your heart?
Fichtenbaum CJ
AIDS Clin Care; 2003 Aug; 15(8):69-73, 76. PubMed ID: 12945527
[No Abstract] [Full Text] [Related]
2. HIV and cardiovascular risk factors.
Falusi OM; Aberg JA
AIDS Read; 2001 May; 11(5):263-8. PubMed ID: 11392695
[TBL] [Abstract][Full Text] [Related]
3. Does antiretroviral-induced hyperlipidaemia constitute a cardiovascular risk?
Gilleece Y; Nelson M
J HIV Ther; 2001 May; 6(2):37-9. PubMed ID: 11501202
[No Abstract] [Full Text] [Related]
4. Cardiovascular disease and toxicities related to HIV infection and its therapies.
Zareba KM; Miller TL; Lipshultz SE
Expert Opin Drug Saf; 2005 Nov; 4(6):1017-25. PubMed ID: 16255661
[TBL] [Abstract][Full Text] [Related]
5. The metabolic syndrome, an epidemic among HIV-infected patients on HAART.
Jevtović DJ; Dragović G; Salemović D; Ranin J; Djurković-Djaković O
Biomed Pharmacother; 2009 Jun; 63(5):337-42. PubMed ID: 18996676
[TBL] [Abstract][Full Text] [Related]
6. HAART to heart talk.
Huff B
GMHC Treat Issues; 2003 Apr; 17(4):8-9. PubMed ID: 12751445
[No Abstract] [Full Text] [Related]
7. The use of lipid-lowering agents in HIV-infected patients.
Meienberg F; Battegay E; Bucher HC; Battegay M
J HIV Ther; 2001 May; 6(2):40-4. PubMed ID: 11501203
[No Abstract] [Full Text] [Related]
8. Impact of dyslipidemia associated with Highly Active Antiretroviral Therapy (HAART) on cardiovascular risk and life expectancy.
Grover SA; Coupal L; Gilmore N; Mukherjee J
Am J Cardiol; 2005 Mar; 95(5):586-91. PubMed ID: 15721096
[TBL] [Abstract][Full Text] [Related]
9. Highly active antiretroviral therapy-associated metabolic syndrome: pathogenesis and cardiovascular risk.
Barbaro G
Am J Ther; 2006; 13(3):248-60. PubMed ID: 16772767
[TBL] [Abstract][Full Text] [Related]
10. Dyslipidaemia associated with antiretroviral therapy in HIV-infected patients.
Calza L; Manfredi R; Chiodo F
J Antimicrob Chemother; 2004 Jan; 53(1):10-4. PubMed ID: 14645323
[TBL] [Abstract][Full Text] [Related]
11. Care of the HIV-positive patient in the emergency department in the era of highly active antiretroviral therapy.
Venkat A; Piontkowsky DM; Cooney RR; Srivastava AK; Suares GA; Heidelberger CP
Ann Emerg Med; 2008 Sep; 52(3):274-85. PubMed ID: 18358567
[TBL] [Abstract][Full Text] [Related]
12. Dyslipidaemia and cardiovascular risk in HIV infection.
Kulasekaram R; Peters BS; Wierzbicki AS
Curr Med Res Opin; 2005 Nov; 21(11):1717-25. PubMed ID: 16307691
[TBL] [Abstract][Full Text] [Related]
13. Growing up with perinatal HIV infection: time for a HAART to heart.
Siberry GK; Joyner M; Hutton N
J Pediatr; 2008 Oct; 153(4):456-7. PubMed ID: 18847617
[No Abstract] [Full Text] [Related]
14. Antiretroviral therapy-associated diseases are common in the long-term.
Lanzafame M; Lattuada E; Zoppini G; Vento S
AIDS Res Hum Retroviruses; 2011 Sep; 27(9):931-2. PubMed ID: 21182461
[No Abstract] [Full Text] [Related]
15. What happens to children growing up with HIV infection? It's time for a HAART to heart.
Viganò A; Pattarino G; Cerini C; Zuccotti GV
Expert Rev Anti Infect Ther; 2009 Jun; 7(5):495-8. PubMed ID: 19485788
[No Abstract] [Full Text] [Related]
16. Cardiovascular risk score change in HIV-1-infected patients switched to an atazanavir-based combination antiretroviral regimen.
Colafigli M; Di Giambenedetto S; Bracciale L; Tamburrini E; Cauda R; De Luca A
HIV Med; 2008 Mar; 9(3):172-9. PubMed ID: 18217998
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of cardiovascular risk in HIV patients: clinical implication.
Das S
Int J Clin Pract; 2010 Aug; 64(9):1173-5. PubMed ID: 20653794
[No Abstract] [Full Text] [Related]
18. Risks of cardiovascular disease in patients receiving antiretroviral therapy for HIV infection: implications for treatment.
Steinhart CR; Emons MF
AIDS Read; 2004 Feb; 14(2):86-90, 93-5. PubMed ID: 14997864
[TBL] [Abstract][Full Text] [Related]
19. Antiretroviral therapy in HIV patients: aspects of metabolic complications and mitochondrial toxicity.
ter Hofstede HJ; Burger DM; Koopmans PP
Neth J Med; 2003 Dec; 61(12):393-403. PubMed ID: 15025414
[No Abstract] [Full Text] [Related]
20. First Italian consensus statement on diagnosis, prevention and treatment of cardiovascular complications in HIV-infected patients in the HAART era (2006).
Carosi G; Quiros-Roldan E; Torti C; Antinori A; Bevilacqua M; Bonadonna RC; Bonfanti P; Castagna A; Cauda R; d'Arminio-Monforte A; Di Gregorio P; Di Perri G; Esposito R; Fatuzzo F; Gervasoni C; Giannattasio C; Guaraldi G; Lazzarin A; Lo Caputo S; Maggi P; Mazzotta F; Moroni M; Prestileo T; Ranieri R; Rizzardini G; Russo R; Galli M;
Infection; 2007 Jun; 35(3):134-42. PubMed ID: 17565453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
